Oncoscreen plus burning rock

Oncoscreen plus burning rock PDF,Doc ,Images

[PDF] BurningRock OncoScreen PlusTM Report

19-Nov-2019 is an internal database of Burning Rock Dx with reference to public ... inhibitor (Navurizumab plus Ipilimumab) regardless of their PD-L1 ...
get supplementary file.php?f=

Burning Rock Biotech Limited

core products including OncoScreen Plus™ and LungPlasma™

776P SHR-1701 a bifunctional fusion protein targeting PD-L1 and

a 520-gene panel (OncoScreen Plus Burning Rock Biotech) to identify genetic alter- ations that might be associated with treatment response in 39 pts.

HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired

520 cancer-related genes (OncoScreen Plus; Burning Rock. Biotech Guangzhou

777P A prospective single-arm

https://www.annalsofoncology.org/article/S0923-7534(21)03448-7/pdf

775P Tremelimumab (T) + durvalumab (D) combined with

a 520-gene panel (OncoScreen Plus Burning Rock Biotech) to identify genetic alter- ations that might be associated with treatment response in 39 pts.

[PDF] Figures and Tables

Burning Rock DX OncoScreen Plus. ST25†/ST26/ST27/ST28. 1631. 523 hg19. 100. IDT. Integrated DNA Technologies xGen Pan-Cancer Panel ST04/ST05/ST06.
Cross oncopanelstudyreveals supp ?sequence= &isAllowed=y